LOUISVILLE, KY., March 2, 2016 -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and health care, announced that is has signed an agreement with Marshfield Clinic and facilitate easy integration of opiate prescription histories into electronic medical records (EMRs). The Appriss integration solution provides opiate prescription histories in real-time, at the point-of-care. This increased accessibility is expected to increase prescription monitoring data usage to improve patient safety and combat prescription drug abuse and diversion.
The Appriss secure integration technology provides a variety of options for health IT systems to integrate Prescription Monitoring Program (PMP) data into physician and pharmacist workflows. Physicians and pharmacists currently log into separate websites to retrieve a patient's opiate prescriptions and then cross-reference this data with a patient's health information in other systems. At Marshfield Clinic, the Appriss integration provides instant access to the patient's data within the electronic health records.
"Our Marshfield Clinic physicians have overwhelmingly embraced Appriss' mission of improving prescribing confidence," said Dr. Eric Penniman, East District 4 Medical Director for Primary Care. "Having access to prescription monitoring data directly from within the medication prescribing program has been significant for our physicians and they are universally grateful for this EMR tool."
The benefits of EHR integration and interoperability have long been recognized by Brandeis University's PDMP Center of Excellence (COE). The September 2012 Guidance of PDMP Best Practices recognizes that "integrating PDMP data retrieval with health information exchanges (HIE), electronic health records (EHR), and pharmacy dispensing systems should help reduce the time and effort needed for prescribers and their staff and for pharmacists to access a patient's prescription history." (http://www.pdmpexcellence.org/). The report further details that integration will maximize both the number of users (prescribers and dispensers) receiving the information and the utility for each of those users.
"By providing prescription monitoring data directly at the point-of-care, Marshfield has taken a major step towards improving patient safety in Wisconsin," said Ken Cassell, Vice President of Business Development at Appriss. "Real-time monitoring also saves valuable minutes for providers, helping to ensure the best standard of care for all patients."
For more information about Appriss integration technologies, please visit http://www.appriss.com/pmpgateway.html and http://www.appriss.com/narxcheck.html.
About Appriss
Appriss provides data-driven solutions to fulfill our mission of keeping communities safe and informed. Partnering with public safety, healthcare, and leading private and public companies, Appriss delivers solutions that prevent fraud, mitigate risk, fight crime, ensure compliance, increase public safety and save lives. Appriss' solutions are always backed by excellent customer support with technical agents in the US that are available to help 24x7x365.
For more information, visit www.appriss.com (http://www.appriss.com).
CONTACT: Kathy Sue Bennett
Marketing Manager
Appriss, Inc.
[email protected]


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Washington Post Publisher Will Lewis Steps Down After Layoffs
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 



